dc.contributor.author | Aghebati-Maleki, L | |
dc.contributor.author | Younesi, V | |
dc.contributor.author | Jadidi-Niaragh, F | |
dc.contributor.author | Baradaran, B | |
dc.contributor.author | Majidi, J | |
dc.contributor.author | Yousefi, M | |
dc.date.accessioned | 2018-08-26T08:59:25Z | |
dc.date.available | 2018-08-26T08:59:25Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54805 | |
dc.description.abstract | Receptor tyrosine kinase-like orphan receptor (ROR1) belongs to one of the families of receptor tyrosine kinases (RTKs). RTKs are involved in the various physiologic cellular functions including proliferation, migration, survival, signaling and differentiation. Several RTKs are deregulated in various cancers implying the targeting potential of these molecules in cancer therapy. ROR1 has recently been shown to be expressed in various types of cancer cells but not in normal adult cells. Hence a molecular inhibitor of extracellular domain of ROR1 that inhibits ROR1-cell surface interaction is of great therapeutic importance. In an attempt to develop molecular inhibitors of ROR1, we screened single chain variable fragment (scFv) phage display libraries, Tomlinson I + J, against one specific synthetic oligopeptide from extracellular domain of ROR1 and selected scFvs were characterized using various immunological techniques. Several ROR1 specific scFvs were selected following five rounds of panning procedure. The scFvs showed specific binding to ROR1 using immunological techniques. Our results demonstrate successful isolation and characterization of specific ROR1 scFvs that may have great therapeutic potential in cancer immunotherapy. é 2016/2017 - IOS Press and the authors. All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | Human Antibodies | |
dc.subject | protein tyrosine kinase | |
dc.subject | receptor tyrosine kinase like orphan receptor antibody | |
dc.subject | single chain fragment variable antibody | |
dc.subject | unclassified drug | |
dc.subject | monoclonal antibody | |
dc.subject | peptide library | |
dc.subject | protein binding | |
dc.subject | receptor tyrosine kinase like orphan receptor | |
dc.subject | recombinant protein | |
dc.subject | ROR1 protein, human | |
dc.subject | single chain fragment variable antibody | |
dc.subject | Article | |
dc.subject | binding affinity | |
dc.subject | biopanning | |
dc.subject | chemoluminescence | |
dc.subject | cloning | |
dc.subject | colony forming unit | |
dc.subject | DNA sequence | |
dc.subject | enzyme linked immunosorbent assay | |
dc.subject | functional assessment | |
dc.subject | monoclonal phage enzyme linked immunosorbent assay | |
dc.subject | phage display | |
dc.subject | polyclonal phage enzyme linked immunosorbent assay | |
dc.subject | polymerase chain reaction | |
dc.subject | priority journal | |
dc.subject | screening | |
dc.subject | Western blotting | |
dc.subject | antibody specificity | |
dc.subject | cell surface display | |
dc.subject | chemistry | |
dc.subject | Escherichia coli | |
dc.subject | gene expression | |
dc.subject | genetics | |
dc.subject | human | |
dc.subject | immunology | |
dc.subject | isolation and purification | |
dc.subject | metabolism | |
dc.subject | molecular cloning | |
dc.subject | peptide library | |
dc.subject | protein domain | |
dc.subject | Antibodies, Monoclonal | |
dc.subject | Antibody Specificity | |
dc.subject | Cell Surface Display Techniques | |
dc.subject | Cloning, Molecular | |
dc.subject | Enzyme-Linked Immunosorbent Assay | |
dc.subject | Escherichia coli | |
dc.subject | Gene Expression | |
dc.subject | Humans | |
dc.subject | Peptide Library | |
dc.subject | Protein Binding | |
dc.subject | Protein Domains | |
dc.subject | Receptor Tyrosine Kinase-like Orphan Receptors | |
dc.subject | Recombinant Proteins | |
dc.subject | Single-Chain Antibodies | |
dc.title | Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique | |
dc.type | Editorial | |
dc.citation.volume | 25 | |
dc.citation.issue | 2 | |
dc.citation.spage | 57 | |
dc.citation.epage | 63 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.3233/HAB-170310 | |